People who carry the gene variant associated with the strongest risk for Alzheimer’s disease may lose their ability to detect odors earlier than people who do not carry the gene variant, which may be an early sign of future memory and thinking problems, according to a study published in the July 26, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the Paris Agreement – Biotech Investments
EQS-News: SCHOTT Pharma AG & Co. KGaA / Key word(s): ESG SCHOTT Pharma reinforces commitment to align its climate actions to the requirements of the